Cargando…

Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update

The intricate relationship between metabolic-associated fatty liver disease (MAFLD) and maternal complications has rapidly become a significant health threat in pregnant women. The presence of MAFLD in pregnancy increases the maternal risk of metabolic complications and comorbidities for both mother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fouda, Sherouk, Vennikandam, Madhu Mathew, Pappachan, Joseph M., Fernandez, Cornelius J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547252/ https://www.ncbi.nlm.nih.gov/pubmed/36304500 http://dx.doi.org/10.14218/JCTH.2022.00052

Ejemplares similares

Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease
por: Jeeyavudeen, Mohammad Sadiq, et al.
Publicado: (2023)

Management of metabolic-associated fatty liver disease: The diabetology perspective
por: Jeeyavudeen, Mohammad Sadiq, et al.
Publicado: (2023)

Metabolic complications of hepatitis C virus infection
por: Chaudhari, Rahul, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease: A Clinical Update
por: Pappachan, Joseph M, et al.
Publicado: (2017)

Diabetic heart disease: A clinical update
por: Rajbhandari, Jake, et al.
Publicado: (2021)

Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease
por: Zhou, Xiu, et al.
Publicado: (2020)

Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update
por: James, Cornelius Fernandez, et al.
Publicado: (2022)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Paraumbilical Varix Masquerading as a Gastric Submucosal Nodule in Decompensated Liver Cirrhosis
por: Varghese, Teresa, et al.
Publicado: (2022)

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
por: Rodríguez-Sanabria, J. Samael, et al.
Publicado: (2022)

Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
por: Alharthi, Jawaher, et al.
Publicado: (2022)

Update on genetics and epigenetics in metabolic associated fatty liver disease
por: Zhu, Xiaopeng, et al.
Publicado: (2022)

A Curious Case of Splenic Leiomyosarcoma of Vascular Origin in a Post–Liver Transplant Recipient
por: Roy, Neil, et al.
Publicado: (2022)

Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
por: Barchetta, Ilaria, et al.
Publicado: (2020)

A Rare Cause and Alternative Algorithm for the Treatment of Gastrointestinal (GI) Bleed: Complications of a Failed Pancreatic Transplant
por: Afzal, Soha, et al.
Publicado: (2023)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
por: Yeh, Ming-Lun, et al.
Publicado: (2023)

Male Obesity-related Secondary Hypogonadism – Pathophysiology, Clinical Implications and Management
por: Fernandez, Cornelius J, et al.
Publicado: (2019)

Tumor Lysis Syndrome in a Patient With Gastric Adenocarcinoma
por: Lingamaneni, Prasanth, et al.
Publicado: (2020)

Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
por: Sangro, Paloma, et al.
Publicado: (2023)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

Diabetes mellitus and stroke: A clinical update
por: Tun, Nyo Nyo, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease and diabetic retinopathy: Is there an association?
por: Jacob, Mathew, et al.
Publicado: (2023)

Metabolic-associated fatty liver disease and lipoprotein metabolism
por: Heeren, Joerg, et al.
Publicado: (2021)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
por: Alomari, Mohammad, et al.
Publicado: (2023)

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease
por: Lin, Huapeng, et al.
Publicado: (2021)

Macrophages in metabolic associated fatty liver disease
por: Alharthi, Jawaher, et al.
Publicado: (2020)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
por: Abou Assi, Reem, et al.
Publicado: (2021)

Discrepancies in the clinical and radiological profiles of COVID-19: A case-based discussion and review of literature
por: Kumar, Hemant, et al.
Publicado: (2021)

Simultaneous pancreas-kidney transplantation for end-stage renal failure in type 1 diabetes mellitus: Current perspectives
por: Nagendra, Lakshmi, et al.
Publicado: (2023)

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease
por: Zeng, Minghui, et al.
Publicado: (2023)

Update on Pparγ and Nonalcoholic Fatty Liver Disease
por: Ables, Gene P.
Publicado: (2012)

Non-alcoholic fatty liver disease: an update on diagnosis
por: DUMITRASCU, DAN L., et al.
Publicado: (2018)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
por: Kang, Seong Hee, et al.
Publicado: (2021)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome
por: Zhou, Xiu, et al.
Publicado: (2019)

Diagnostic ability using fatty liver and metabolic markers for metabolic‐associated fatty liver disease stratified by metabolic/glycemic abnormalities
por: Okada, Akira, et al.
Publicado: (2022)

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
por: Hliwa, Aleksandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9psb0tp6eh0m8pb5a7db5o1kr0